Is Brown & Brown, Inc. (BRO) a Buy Now? Citigroup Turns Bullish on Valuation Opportunity

We recently compiled a list of the 8 Most Oversold Large Cap Stocks to Buy. Brown & Brown, Inc. (NYSE:BRO) is among the best oversold stocks to invest in.

TheFly reported on May 7 that BRO was upgraded by Citigroup from Neutral to Buy, while the price target remained unchanged at $70. The firm also raised its outlook on several insurance brokerage companies, pointing to valuation as the primary driver behind the change. It noted that current cyclical pressures affecting growth are expected to moderate over the coming quarters, which could create broader upside potential across the sector as conditions normalize and support improved investor returns.

Is Brown & Brown, Inc. (BRO) a Buy Now? Citigroup Turns Bullish on Valuation Opportunity

Separately, earlier, on April 28, Brown & Brown, Inc. (NYSE:BRO) reported first-quarter results showing earnings per share of $1.39, slightly above analyst expectations of $1.36. Revenue for the quarter came in at $1.90 billion, also modestly ahead of consensus estimates of $1.89 billion. Management highlighted that employees continued to support clients effectively despite a challenging environment for growth across the insurance sector. The results reflected steady operational performance, with both top and bottom line figures exceeding market forecasts, indicating resilience in the company’s core brokerage operations during the period.

Brown & Brown, Inc. (NYSE:BRO) is a global insurance brokerage based in Daytona Beach. It provides insurance, reinsurance, and risk management solutions for businesses, governments, and individuals through a decentralized network of offices worldwide.

While we acknowledge the risk and potential of BRO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BRO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Cancer Stocks to Buy for the Long Term and 10 Most Popular Stocks on Robinhood in 2026.

Disclosure: None. Follow Insider Monkey on Google News.